
51 - 200 employees
🏥 Healthcare
💊 Pharmaceuticals
🧬 Biotechnology
💰 $259M Post-IPO Equity on 2022-12
Healthcare • Pharmaceuticals • Biotechnology
Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). The company achieved a significant milestone with the accelerated FDA approval of its first therapy for adults with NASH with moderate to advanced liver fibrosis. Madrigal is actively conducting a Phase 3 trial for the treatment of NASH with compensated cirrhosis. The company is dedicated to improving care for patients with NASH/MASH through its ambitious research programs and therapeutic developments.
Selected: 🆕 Date Added.
🔥 8 hours ago
Regional Sales Director leading Area Business Managers and regional sales strategy for Madrigal’s MASH therapy, Rezdiffra. Driving compliant healthcare-provider engagement, launches, and sales performance across the South Central region.
🤠 Texas – Remote
💵 $216k - $265k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🔴 Lead
🤑 Sales
🦅 H1B Visa Sponsor
👻 Ghost score 2%
🕒 October 5
Regional Scientific Director advancing Madrigal’s Rezdiffra MASH therapeutics across payer and health-system networks. Providing scientific, HEOR, and medical support across New England and Minnesota.
🗻 New Hampshire, Massachusetts, +3 more states – Remote
💵 $224k - $274k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 2%
🕒 September 22
Director leading field execution, national meetings, and cross-functional programs for Madrigal’s MASH therapeutics commercialization. Driving field readiness, adoption, process improvement, budgets, and vendor performance.
🇺🇸 United States – Remote
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 12%
🕒 September 15
Associate Director overseeing specialty pharmacy operations for Madrigal’s MASH therapeutics. Driving patient access, vendor performance, compliance, and Rezdiffra program outcomes.
🍂 Massachusetts, Pennsylvania – Remote
💵 $180k - $221k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
⚙️ Operations
🦅 H1B Visa Sponsor
👻 Ghost score 2%
🕒 August 13
Senior Director overseeing QA disposition and clinical supply release for Madrigal, a biopharmaceutical company developing MASH therapeutics. Ensuring compliant operations, inspection readiness, and vendor governance.
🇺🇸 United States – Remote
💵 $244.6k - $299k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🦅 H1B Visa Sponsor
👻 Ghost score 7%
🕒 April 30
Senior Manager responsible for overseeing GCP Quality Assurance at Madrigal. Managing clinical trial compliance and quality systems in the biopharmaceutical industry.
🔔 Pennsylvania – Remote
💵 $147k - $180k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
🔧 QA Engineer (Quality Assurance)
🦅 H1B Visa Sponsor
👻 Ghost score 33%